期刊
AMERICAN JOURNAL OF TRANSPLANTATION
卷 11, 期 11, 页码 2297-2301出版社
WILEY
DOI: 10.1111/j.1600-6143.2011.03750.x
关键词
Acutemyocardial infarction; bone marrow-derived cells; cell transplantation therapy; chronic heart failure
Over the last decade, many investigators have utilized bone marrow-derived cells for cell transplantation therapy in animal studies and in patients with acute myocardial infarction and chronic heart failure. In those experimental and clinical studies, various doses and types of bone marrow-derived cells have been transplanted to the injured myocardium using a variety of approaches, such as intracoronary infusion or catheter-based direct endomyocardial injection, and at different time points after successful coronary reperfusion. The reported treatment effects are variable, which may be related to differences in cell type and quantity of transplanted cells, timing and approach of cell transplantation and patient selection. In this review, we summarize and discuss the controversies and questions related to the clinical use of bone marrow-derived cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据